NCT01295944 2025-08-05
Carboplatin and Bevacizumab for Recurrent Ependymoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
Societe Internationale d'Oncologie Pediatrique
Children's Oncology Group